3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced

Zhaoyang Fan1, John Sheehan, Xiaoming Bi

  • 1Department of Radiology, Northwestern University, Chicago, Illinois, USA.

Insights

A new noncontrast MR angiography (MRA) technique uses flow-sensitive dephasing (FSD) to visualize lower extremity arteries without contrast agents. This method is a promising alternative for patients with kidney issues, offering clear imaging of peripheral arterial disease.

Area of Science:

  • Medical Imaging
  • Cardiovascular Imaging
  • Magnetic Resonance Imaging

Background:

  • Contrast-enhanced MR angiography (MRA) is standard for peripheral arterial disease (PAD).
  • Renal insufficiency raises safety concerns regarding contrast agents.
  • This necessitates the development of noncontrast MRA techniques.

Purpose of the Study:

  • To develop and evaluate a novel noncontrast MRA technique for the distal lower extremities.
  • To assess the efficacy of flow-sensitive dephasing (FSD) preparation for arterial signal void.
  • To provide a safe imaging alternative for PAD patients with renal insufficiency.

Main Methods:

  • Electrocardiography-triggered, 3D segmented balanced steady-state free precession (bSSFP) with FSD preparation.
  • FSD magnetization preparation to induce arterial flow voids during systole.
  • Magnitude image subtraction between dark-artery (systole, FSD) and bright-artery (diastole, no FSD) scans.

Main Results:

  • Optimized FSD parameters achieved excellent MRA image quality in healthy volunteers.
  • The technique successfully identified arterial stenosis and occlusion in PAD patients.
  • Noncontrast MRA findings were confirmed by contrast-enhanced MRA.

Conclusions:

  • FSD-prepared bSSFP MRA with ECG gating and subtraction is a viable noncontrast imaging strategy.
  • This technique offers a promising alternative for distal lower extremity MRA in patients with renal insufficiency.
  • Further validation may establish this as a clinical standard for PAD assessment.